CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events

On December 22, 2020, Creative Medical Technologies, Inc. (the "Company"), issued a press release identifying one of the primary mechanisms of action of its ImmCelz® product in the treatment of stroke.

On December 29, 2020, the Company issued a press release reporting on data and a related patent filing with respect to the ability of ImmCelz® to reverse liver failure in the carbon tetrachloride preclinical model of hepatocyte necrosis.

On December 31, 2020, the Company issued a press release reporting on a patent filing based on positive preclinical data using ImmCelz® in the treatment of a model of heart attack.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



  Exhibit   Press Releases issued by the Company dated December 22, 2020
99.1

  Exhibit   Press Releases issued by the Company dated December 29, 2020
99.2

  Exhibit   Press Releases issued by the Company dated December 31, 2020
99.3





2

© Edgar Online, source Glimpses